The efficacy of [99mTc]Tc-HYNIC-PSMA SPECT/CT in detecting primary lesions and metastases in newly diagnosed prostate cancer has recently been demonstrated (Wang et al. 2023). The gene discussed is FOLH1; the disease is prostate carcinoma.